The treatment of cryptogenic fibrosing alveolitis with immunosuppressant drugs.
D000328:Adult; D000372:Agglutination Tests; D000974:Antibodies, Antinuclear / Q000032:analysis; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use*; D002699:Chlorambucil / Q000627:therapeutic use*; D003168:Complement Fixation Tests; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000150:complications; D011241:Prednisone / Q000009:adverse effects; D011658:Pulmonary Fibrosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D011859:Radiography; D012217:Rheumatoid Factor / Q000032:analysis; D013147:Spirometry; D013921:Thrombocytopenia / Q000139:chemically induced
D000974:Antibodies, Antinuclear; D007166:Immunosuppressive Agents; D002699:Chlorambucil; D003520:Cyclophosphamide; D012217:Rheumatoid Factor; D001379:Azathioprine; D011241:Prednisone